Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125740001 | 12574000 | 1 | I | 20160705 | 20160720 | 20160720 | EXP | SE-TEVA-675389ISR | TEVA | 50.00 | YR | F | Y | 0.00000 | 20160720 | CN | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125740001 | 12574000 | 1 | SS | Omeprazol | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 125740001 | 12574000 | 2 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | 76465 | TABLET | |||||||||
| 125740001 | 12574000 | 3 | SS | Pramipexol | PRAMIPEXOLE | 1 | U | 77724 | .35 | MG | TABLET | ||||||||
| 125740001 | 12574000 | 4 | SS | Devitre | CHOLECALCIFEROL | 1 | U | 0 | CHEWABLE TABLET | ||||||||||
| 125740001 | 12574000 | 5 | SS | Oralovite | ASCORBIC ACIDNIACINAMIDEPYRIDOXINERIBOFLAVINTHIAMINE | 1 | Oral | U | 0 | FILM-COATED TABLET | |||||||||
| 125740001 | 12574000 | 6 | SS | Betolvidon | CYANOCOBALAMIN | 1 | U | 0 | 1 | MG | TABLET | ||||||||
| 125740001 | 12574000 | 7 | SS | Folacin | FOLIC ACID | 1 | U | 0 | TABLET | ||||||||||
| 125740001 | 12574000 | 8 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | U | 0 | 25 | MG | TABLET | ||||||||
| 125740001 | 12574000 | 9 | SS | LASIX | FUROSEMIDE | 1 | U | 0 | CAPSULE, HARD | ||||||||||
| 125740001 | 12574000 | 10 | SS | Duodopa | CARBIDOPALEVODOPA | 1 | U | 0 | GEL | ||||||||||
| 125740001 | 12574000 | 11 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | U | 0 | TABLET | |||||||||
| 125740001 | 12574000 | 12 | SS | Oprymea | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | U | 0 | .26 | MG | TABLET | ||||||||
| 125740001 | 12574000 | 13 | SS | Selegiline | SELEGILINE | 1 | Oral | U | 0 | 10 | MG | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125740001 | 12574000 | LT |
| 125740001 | 12574000 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125740001 | 12574000 | Hypomagnesaemia | |
| 125740001 | 12574000 | Hyponatraemia | |
| 125740001 | 12574000 | Neuroleptic malignant syndrome | |
| 125740001 | 12574000 | Rhabdomyolysis | |
| 125740001 | 12574000 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |